These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 23130662

  • 1. Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology.
    Shashni B, Sakharkar KR, Nagasaki Y, Sakharkar MK.
    J Drug Target; 2013 Feb; 21(2):161-74. PubMed ID: 23130662
    [Abstract] [Full Text] [Related]

  • 2. PPARγ disease gene network and identification of therapeutic targets for prostate cancer.
    Venkatachalam G, Kumar AP, Sakharkar KR, Thangavel S, Clement MV, Sakharkar MK.
    J Drug Target; 2011 Nov; 19(9):781-96. PubMed ID: 21780947
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
    Zaytseva YY, Wallis NK, Southard RC, Kilgore MW.
    Anticancer Res; 2011 Mar; 31(3):813-23. PubMed ID: 21498701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of insulin-like growth factor binding protein-3 in peroxisome proliferator-activated receptor gamma-mediated inhibition of breast cancer cell growth.
    Pon CK, Firth SM, Baxter RC.
    Mol Cell Endocrinol; 2015 Jan 05; 399():354-61. PubMed ID: 25449421
    [Abstract] [Full Text] [Related]

  • 10. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
    Allred CD, Kilgore MW.
    Mol Cell Endocrinol; 2005 May 12; 235(1-2):21-9. PubMed ID: 15866424
    [Abstract] [Full Text] [Related]

  • 11. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 12; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 12. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH.
    Cell Biol Int; 2008 Aug 12; 32(8):906-12. PubMed ID: 18474441
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ.
    Mol Carcinog; 2002 Aug 12; 34(4):165-71. PubMed ID: 12203367
    [Abstract] [Full Text] [Related]

  • 14. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells.
    Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP.
    J Lipid Res; 2002 Nov 12; 43(11):1818-28. PubMed ID: 12401880
    [Abstract] [Full Text] [Related]

  • 15. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 12; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 16. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B, Gottlieb E.
    Trends Biochem Sci; 2012 Aug 12; 37(8):309-16. PubMed ID: 22626471
    [Abstract] [Full Text] [Related]

  • 17. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 12; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 18. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
    Zhou Z, Liu Y, Qin M, Sheng W, Wang X, Li Z, Zhong R.
    J Photochem Photobiol B; 2014 May 05; 134():1-8. PubMed ID: 24792468
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL, Zhao Y, Kalus AM, Simpson ER.
    Cancer Res; 2000 Mar 15; 60(6):1604-8. PubMed ID: 10749129
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line.
    Pignatelli M, Cocca C, Santos A, Perez-Castillo A.
    Oncogene; 2003 Aug 21; 22(35):5446-50. PubMed ID: 12934104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.